Pillar 5: Making Medtech Innovation sustainable, durable and scalable in Europe
The following is an opinion piece written by Daniel O’Mahony, partner at Seroba. The piece was written September 2024. Continuous investment into Medtech Innovation, from concept through to clinical trials, regulatory approval, market launch and scalability can deliver patient-centric, digitally advanced, resilient and sustainable health care. Such deliverables will benefit all stakeholders in Europe including patients, doctors, hospitals and payors. …